Cargando…
Supplementation of Weizmannia coagulans BC2000 and Ellagic Acid Inhibits High-Fat-Induced Hypercholesterolemia by Promoting Liver Primary Bile Acid Biosynthesis and Intestinal Cholesterol Excretion in Mice
The probiotic Weizmannia coagulans (W. coagulans) BC2000 can increase the abundance of intestinal transforming ellagic acid (EA) bacteria and inhibit metabolic disorders caused by hyperlipidemia by activating liver autophagy. This study aimed to investigate the inhibitory effects of W. coagulans BC2...
Autores principales: | Jin, Long, Dang, Hongyang, Wu, Jinyong, Yuan, Lixia, Chen, Xiangsong, Yao, Jianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964488/ https://www.ncbi.nlm.nih.gov/pubmed/36838229 http://dx.doi.org/10.3390/microorganisms11020264 |
Ejemplares similares
-
Weizmannia coagulans BC2000 Plus Ellagic Acid Inhibits High-Fat-Induced Insulin Resistance by Remodeling the Gut Microbiota and Activating the Hepatic Autophagy Pathway in Mice
por: Jin, Long, et al.
Publicado: (2022) -
High-Quality Draft Genome Sequence and Characterization of ProBC Plus Weizmannia (Bacillus) coagulans LMG S-31876
por: Kallur, Ranjith Kumar, et al.
Publicado: (2022) -
A Comparative Analysis of Weizmannia coagulans Genomes Unravels the Genetic Potential for Biotechnological Applications
por: Aulitto, Martina, et al.
Publicado: (2022) -
Safety and efficacy of a feed additive consisting of lactic acid produced by Weizmannia coagulans (synonym Bacillus coagulans) DSM 32789 for all animal species except for fish (Jungbunzlauer SA)
por: Azimonti, Giovanna, et al.
Publicado: (2022) -
Draft Genome Sequence of Weizmannia coagulans MB BCM9, a Stable Spore-Forming Probiotic
por: Kaushik, Gaurav, et al.
Publicado: (2023)